rs398092530
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_025074.7(FRAS1):c.3151+14_3151+15dupTG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.361 in 1,561,108 control chromosomes in the GnomAD database, including 103,737 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.38 ( 11138 hom., cov: 0)
Exomes 𝑓: 0.36 ( 92599 hom. )
Consequence
FRAS1
NM_025074.7 intron
NM_025074.7 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.47
Publications
2 publications found
Genes affected
FRAS1 (HGNC:19185): (Fraser extracellular matrix complex subunit 1) This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
FRAS1 Gene-Disease associations (from GenCC):
- Fraser syndromeInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Fraser syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- renal agenesis, unilateralInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 4-78374264-C-CTG is Benign according to our data. Variant chr4-78374264-C-CTG is described in ClinVar as Benign. ClinVar VariationId is 261806.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.462 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FRAS1 | ENST00000512123.4 | c.3151+14_3151+15dupTG | intron_variant | Intron 25 of 73 | 5 | NM_025074.7 | ENSP00000422834.2 | |||
| FRAS1 | ENST00000325942.11 | c.3151+14_3151+15dupTG | intron_variant | Intron 25 of 41 | 1 | ENSP00000326330.6 | ||||
| FRAS1 | ENST00000682513.1 | c.3151+14_3151+15dupTG | intron_variant | Intron 25 of 63 | ENSP00000508201.1 | |||||
| FRAS1 | ENST00000684159.1 | c.3151+14_3151+15dupTG | intron_variant | Intron 25 of 44 | ENSP00000506875.1 |
Frequencies
GnomAD3 genomes AF: 0.379 AC: 57478AN: 151822Hom.: 11129 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
57478
AN:
151822
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.337 AC: 82353AN: 244358 AF XY: 0.331 show subpopulations
GnomAD2 exomes
AF:
AC:
82353
AN:
244358
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.359 AC: 505254AN: 1409168Hom.: 92599 Cov.: 30 AF XY: 0.354 AC XY: 245645AN XY: 694690 show subpopulations
GnomAD4 exome
AF:
AC:
505254
AN:
1409168
Hom.:
Cov.:
30
AF XY:
AC XY:
245645
AN XY:
694690
show subpopulations
African (AFR)
AF:
AC:
15318
AN:
32706
American (AMR)
AF:
AC:
13512
AN:
43752
Ashkenazi Jewish (ASJ)
AF:
AC:
7509
AN:
25072
East Asian (EAS)
AF:
AC:
13234
AN:
38626
South Asian (SAS)
AF:
AC:
18526
AN:
80442
European-Finnish (FIN)
AF:
AC:
16354
AN:
51892
Middle Eastern (MID)
AF:
AC:
1905
AN:
5434
European-Non Finnish (NFE)
AF:
AC:
398390
AN:
1073596
Other (OTH)
AF:
AC:
20506
AN:
57648
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
14590
29180
43769
58359
72949
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13112
26224
39336
52448
65560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.379 AC: 57529AN: 151940Hom.: 11138 Cov.: 0 AF XY: 0.373 AC XY: 27730AN XY: 74294 show subpopulations
GnomAD4 genome
AF:
AC:
57529
AN:
151940
Hom.:
Cov.:
0
AF XY:
AC XY:
27730
AN XY:
74294
show subpopulations
African (AFR)
AF:
AC:
19349
AN:
41376
American (AMR)
AF:
AC:
5261
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1019
AN:
3470
East Asian (EAS)
AF:
AC:
1758
AN:
5164
South Asian (SAS)
AF:
AC:
1079
AN:
4814
European-Finnish (FIN)
AF:
AC:
3291
AN:
10564
Middle Eastern (MID)
AF:
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24632
AN:
67960
Other (OTH)
AF:
AC:
779
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1805
3611
5416
7222
9027
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
542
1084
1626
2168
2710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1010
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Fraser syndrome 1 Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.